Los Angeles, California-based MCTC Holdings (OTC: MCTC) this morning announced that it is expanding its research and development (“R&D”) program designed to produce polymeric nanoparticles of cannabinol (“CBN”). The expansion aims to create nanoparticles of cannabinoid glycosides, which the company believes will hold considerable commercial viability in the future. MCTC’s research team plans to produce CBN nanoparticles with both immediate and controlled-release properties based on the company’s experience producing cannabidiol (“CBD”) nanoparticles and nanofibers. MCTC also added the creation of nanoparticles of cannabinoid glycosides to its research program. “We are continuing our R&D programs based on three primary goals,” MCTC CEO Arman Tabatabaei stated in the news release. “First, we plan to continue toward mass production of immediate and controlled-release CBD nanoparticles and, to a lesser extent, CBD nanofibers. Second, we plan to utilize this experience to replicate the process using some of the minor cannabinoids, with CBN selected as the first target. Lastly, we are focusing all of our research toward protecting the intellectual property we develop. Thus far, we have filed four patents, with one additional application in progress. We are likely to file several more patent applications over the coming months as our cannabinoid R&D programs progress.”
To view the full press release, visit http://cnw.fm/NhHr4
About MCTC Holdings Inc.
MCTC Holdings is a Delaware-registered, fully reporting and audited publicly traded company. With the hemp and cannabis industries developing rapidly and with a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization for exotic cannabinoid isolation as well as bioenhancement of cannabinoids, polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The company was reorganized in June 2019 and announced its intent to enter the fast-growing cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs. For more information, visit the company’s website at www.CannabisGlobalinc.com.
NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/MCTC
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com
CBDWire is part of the InvestorBrandNetwork.